These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17662552)

  • 21. In vitro activity of tigecycline against gram-positive cocci: a multicentre study in Greece.
    Malli E; Spiliopoulou I; Kolonitsiou F; Neocleous Ch; Klapsa D; Pantelidi K; Panopoulou M; Grapsa S; Alepopoulou E; Neonakis I; Alexiou-Daniel S; Bakola D; Koutsia-Carouzou C; Malamou-Lada H; Zerva L; Vlahaki E; Kartali-Ktenidou S; Anastassiou E; Petinaki E
    J Antimicrob Chemother; 2008 Nov; 62(5):1158-60. PubMed ID: 18753190
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections.
    Sader HS; Mallick R; Kuznik A; Fritsche TR; Jones RN
    Int J Antimicrob Agents; 2007 Dec; 30(6):514-20. PubMed ID: 17959359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
    Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro antimicrobial activity of tigecycline against clinical isolates of vancomycin-resistant enterococcus.
    Yemisen M; Demirel A; Mete B; Kaygusuz A; Mert A; Tabak F; Ozturk R
    Indian J Med Microbiol; 2009; 27(4):373-4. PubMed ID: 19736414
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of different Mueller-Hinton agars and media age on Etest susceptibility testing of tigecycline.
    Tan TY; Ng LS; Chen DM
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):93-5. PubMed ID: 20727479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina.
    Fernández Canigia L; Kaufman S; Lanata L; Vay C; Giovanakis M; Bantar C;
    Chemotherapy; 2009; 55(1):20-7. PubMed ID: 18974645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing the role of tigecycline in an era of antimicrobial resistance.
    Schafer JJ; Goff DA
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tigecycline in-vitro susceptibility and antibiotics' fitness for gram-negative pathogens.
    Arya SC; Agarwal N
    Saudi Med J; 2008 Nov; 29(11):1558-60. PubMed ID: 18998000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline in vitro activity of tigecycline among key bacterial pathogens exhibiting multidrug resistance.
    Draghi DC; Tench S; Dowzicky MJ; Sahm DF
    Chemotherapy; 2008; 54(2):91-100. PubMed ID: 18303257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of tigecycline against multiple strains of Borrelia burgdorferi.
    Yang X; Nguyen A; Qiu D; Luft BJ
    J Antimicrob Chemother; 2009 Apr; 63(4):709-12. PubMed ID: 19182236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial.
    Denys GA; Koch KM; Dowzicky MJ
    Am J Infect Control; 2007 Oct; 35(8):521-6. PubMed ID: 17936143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
    Koomanachai P; Kim A; Nicolau DP
    J Antimicrob Chemother; 2009 May; 63(5):982-7. PubMed ID: 19279050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies.
    Entenza JM; Moreillon P
    Int J Antimicrob Agents; 2009 Jul; 34(1):8.e1-9. PubMed ID: 19162449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).
    Bouchillon SK; Iredell JR; Barkham T; Lee K; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Feb; 33(2):130-6. PubMed ID: 18995992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic efficacy, animal models and experimental pharmacodynamics: what do we know about tigecycline?].
    Giménez MJ; Barberán J; Aguilar L
    Rev Esp Quimioter; 2007 Dec; 20(4):387-94. PubMed ID: 18563212
    [No Abstract]   [Full Text] [Related]  

  • 36. A pharmacodynamic simulation to assess tigecycline efficacy for hospital-acquired pneumonia compared with other common intravenous antibiotics.
    Kuti JL; Dowzicky M; Nicolau DP
    J Chemother; 2008 Feb; 20(1):69-76. PubMed ID: 18343747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial activity and pharmacokinetics/pharmacodynamics of the novel glycylcycline, tigecycline.
    Peterson LR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):163-4. PubMed ID: 16105559
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
    Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
    Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs).
    Ong CT; Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2005 Sep; 56(3):498-501. PubMed ID: 16024591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation and reproducibility assessment of tigecycline MIC determinations by Etest.
    Bolmström A; Karlsson A; Engelhardt A; Ho P; Petersen PJ; Bradford PA; Jones CH
    J Clin Microbiol; 2007 Aug; 45(8):2474-9. PubMed ID: 17522277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.